← Back to Search

CatchU App for Fall Injury Prevention (CatchU Trial)

N/A
Recruiting
Led By Jeannette R Mahoney, PhD
Research Sponsored by Jeannette Mahoney
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

CatchU Trial Summary

This trial is testing a new iPhone app called CatchU that is designed to help assess a person's risk of falling. The app uses information from multiple senses to try and predict falls and then give that information to a physician who can then provide counseling to try and prevent falls.

Who is the study for?
The CatchU study is for English-speaking adults aged 65+ living in the New York Metropolitan area who can walk with or without aids like canes. They should be able to visit a clinic and not have severe medical conditions, dementia, major mobility issues due to musculoskeletal pain, progressive neurological diseases, severe sensory impairments, or any psychiatric symptoms that could interfere with the study.Check my eligibility
What is being tested?
CatchU Intervention is being tested; it's an iPhone app designed to assess fall risk in older adults. The trial aims to show how well this app predicts falls by using it during clinical visits and follow-up telehealth calls. This pilot study will involve 300 patients over two years.See study design
What are the potential side effects?
Since CatchU is a non-invasive assessment tool used on an iPhone, there are no direct physical side effects associated with its use. However, participants may experience discomfort or anxiety while engaging with technology or discussing their fall risks.

CatchU Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Falls

CatchU Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CatchU InterventionExperimental Treatment1 Intervention
Placement into the intervention vs. control group is random, but dependent upon multisensory integration performance. VSI - (poor) integrators, will be randomly assigned into either the intervention or control group to test the beneficial effect of the CatchU intervention. Participants in the Intervention arm will be monitored every two months to determine falls history, but will also receive the CatchU intervention which consists of physicians relaying individualized recommendations from the CatchU physician report to the participant, as well as providing the participant with falls intervention referrals and falls counseling.
Group II: ControlActive Control1 Intervention
Placement into the intervention vs. control group is random, but dependent upon multisensory integration performance. Meaning, older adults who are enrolled and screened with good integration abilities on the CatchU test (aka: VSI + (good) integrators), (VSI = visual-somatosensory integration) will not be placed in either the intervention or control group since better visual-somatosensory integration performance has been linked to better cognitive and motor outcomes. These participants will be included in examination of additional study aims not related to the intervention. VSI - (poor) integrators, will be randomly assigned into either the intervention or control group to test the beneficial effect of the CatchU intervention. Participants in the Control arm will be monitored every two months via telephone surveys to determine falls history, but will not receive the CatchU intervention.

Find a Location

Who is running the clinical trial?

Jeannette MahoneyLead Sponsor
Burke Rehabilitation HospitalOTHER
8 Previous Clinical Trials
661 Total Patients Enrolled
Albert Einstein College of MedicineOTHER
287 Previous Clinical Trials
11,856,808 Total Patients Enrolled

Media Library

CatchU Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05544760 — N/A
Sensory Disorders Research Study Groups: Control, CatchU Intervention
Sensory Disorders Clinical Trial 2023: CatchU Intervention Highlights & Side Effects. Trial Name: NCT05544760 — N/A
CatchU Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05544760 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there a possibility to join this research endeavor?

"Based on the clinicaltrials.gov data, this trial is actively seeking participants and has been since its inception on October 13th 2022. The last update was also on that day."

Answered by AI

How many participants are included in this research endeavor?

"Affirmative. The research study has been made available on clinicaltrials.gov since October 13th 2022, and is actively enrolling patients at this time. 300 people need to be recruited from two distinct medical facilities."

Answered by AI

Who else is applying?

What state do they live in?
Ohio
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
CatchU: A Quantitative Multisensory Falls-Assessment Study
Jeannette Mahoney 2022. "CatchU: A Quantitative Multisensory Falls-Assessment Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05544760.
All > Aging
~75 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top